Advanced Lymphoid Leukemia clinical trials

Explore recruiting advanced lymphoid leukemia clinical trials.

Recruiting advanced lymphoid leukemia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Lymphoid Leukemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Long-term follow-up study of patients who have previously been exposed to UCART19 (allogeneic engineered T-cells expressing a lentiviral-based anti-CD19 chimeric antigen receptor)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Advanced Lymphoid Leukemia trials by city

Advanced Lymphoid Leukemia clinical trials

Recruiting advanced lymphoid leukemia studies right now

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

Evaluation of Skin Tests in Biotherapy Allergies

Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

Also recruiting in Europe

Long-term follow-up study of patients who have previously been exposed to UCART19 (allogeneic engineered T-cells expressing a lentiviral-based anti-CD19 chimeric antigen receptor)

Advanced Lymphoid Leukemia trials by city

Other conditions